JUN 06, 2016 12:04 PM PDT

Hand-Held Heart Attack Detector

WRITTEN BY: Xuan Pham
Emergency room doctors can now diagnose a potential heart attack in 10 minutes instead of the usual hour-long wait for routine lab results. This leap in diagnostic efficiency is thanks to a new hand-held device that analyzes cardiac-specific proteins from a single drop of blood.
 
Philips Communications





Known as the Minicare I-20, the device resembles a common label maker. But in this portable device, Philips Healthcare has packed a quite punch. The device works by measuring the level of the biomarker cardiac troponin I (cTnI), which is a heart-specific protein that leaks into the bloodstream following a heart attack. Doctors rely on the presence of this biomarker to diagnose and confirm myocardial infarction in patients who present with chest pains. But waiting for these routine lab tests cost precious time in the ER.
 
"Blood samples are usually analyzed in the hospital laboratory, which can easily take more than an hour to get the result back to the ED physician. Point-of-care testing can significantly help to reduce the turnaround time," said Paul Collinson, consultant chemical pathologist at St. George's University Hospital in the United Kingdom.
 
With the portable device, doctors can have their patient’s biomarker results even before they complete taking the patient’s medical history. And in a setting where every minute counts, the Minicare I-20 could be life-saving, especially for high-risk cardiac patients.
 
"Minicare I-20 is designed to help care providers to reduce time to treatment and reduce time to discharge of patients, thereby helping to decrease crowding in the emergency department and leading to better use of hospital resources," said Marcel van Kasteel, CEO of Handheld Diagnostics at Philips.
 
The device passed expectations in multicenter clinical studies and in real acute hospital settings. In all validation tests, the device dramatically cuts down the diagnostic time, often exceeding a turn-around time of less than 10 minutes.
 
Philips has plans to extend the applications of the Minicare I-20 to other blood tests, broadening the scope of this point-of-care device. Currently, the device has not made its way to the US market yet, but it is available in the United Kingdom, Germany, and the Netherlands.
 


Additional source: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
JUN 05, 2018
Clinical & Molecular DX
JUN 05, 2018
"ImmunoPET" Imaging Identifies IBD Inflammation
Scientists are now applying PET imaging to detect inflammation in people with inflammatory bowel disease (IBD). This could help countless IBD patients conn...
JUN 07, 2018
Genetics & Genomics
JUN 07, 2018
Easily Identifying Pregnancies at Risk for Premature Birth
Premature birth affects almost ten percent of pregnancies and is the leading cause of infant mortality in the US....
JUN 16, 2018
Videos
JUN 16, 2018
What is Preimplantation Genetic Diagnosis?
All parents want a healthy baby, and for some people that carry genetic mutations, the decision to have children presents a challenge....
JUL 02, 2018
Cardiology
JUL 02, 2018
AF Treatment Zaps Faulty Heart Tissue
Treating atrial fibrillation (AF), the most common type of arrhythmia, with what was previously a last-resort therapeutic approach will help reduce the ris...
OCT 21, 2018
Genetics & Genomics
OCT 21, 2018
The Genetic Cause of Severe Childhood Epilepsy is Revealed
This work has opened up new therapeutic avenues that the scientists will be exploring....
NOV 07, 2018
Genetics & Genomics
NOV 07, 2018
Hunting Down the microRNAs That Influence Disease
Researchers want to identify the tiny, non-coding RNAs that control gene expression - and contribute to disease....
Loading Comments...